Close Search
JDDonline - Journal of Drugs in Dermatology
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In
  • x-twitter facebook linkedin instagram
Dec 10
Love0

Double Blind, Placebo Controlled Evaluation of a Novel Skin Lightening Agent

By No Comments
INTRODUCTIONMelasma is a chronic, often refractory disorder characterized by irregular patches of hyperpigmentation in a symmetric distribution on the sun exposed area of the face. It is most often seen…
Read More
Dec 10
Love0

Realistic Sunscreen Durability: A Randomized, Double-blinded, Controlled Clinical Study

By No Comments
INTRODUCTIONThe American Academy of Dermatology and US Food and Drug Administration (FDA) recommend reapplying sunscreen at 2-hour intervals.1,2 Sun protection factor (SPF) of sunscreens is tested with a 2-mg/cm2 application…
Read More
Dec 10
Love0

Eruptive Sebaceous Hyperplasia: A Rare Consequence of Systemic Corticosteroids

By No Comments
CASE PRESENTATIONA 46-year-old Caucasian male with Crohn’s disease presented with a sudden eruption of asymptomatic growths on his face two weeks after the initiation of a protracted course of prednisone,…
Read More
Dec 10
Love0

Trends in Atopic Dermatitis Management: Comparison of 1990-1997 to 2003-2012

By No Comments
INTRODUCTIONAtopic dermatitis (AD) is a common inflammatory skin condition characterized by xerosis, lichenification, and eczematous lesions with severe itch. As there is no cure for this disease, the majority of…
Read More
Dec 10
Love0

Vismodegib Use in Clinical Practice: Analysis of a United States Medical Claims Database

By No Comments
INTRODUCTIONBasal cell carcinoma (BCC), representing approximately 80% of nonmelanoma skin cancers, is the most commonly diagnosed human cancer worldwide,1 and some evidence suggests that the worldwide incidence of BCC is…
Read More
Dec 10
Love0

Cross-Sectional Survey of the Burden of Illness of Rosacea by Erythema Severity

By No Comments
INTRODUCTIONRosacea is a chronic skin condition characterized by persistent erythema on the central face that affects an estimated 16 million adults in the United States.1-3 Rosacea can be further categorized…
Read More
Dec 10
Love0

Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype

By No Comments
INTRODUCTIONAcne vulgaris (acne) is the most common dermatologic diagnosis in the United States from childhood through the age of 44 years, reaching its highest prevalence during adolescence and early adulthood.1…
Read More
Dec 10
Love0

Planimetric Post-hoc Analysis of Women With Onychomycosis from Tavaborole 5% Phase III Studies: Evidence of Greater Improvements in Patients With >50% Baseline Infection

By No Comments
INTRODUCTIONOnychomycosis is a chronic fungal infection caused by dermatophytes, yeast, or non-dermatophyte molds and is the most common nail disease, accounting for up to 50% of all nail dystrophies.1 It…
Read More
Dec 10
Love0

Is Severity of Disease a Prognostic Factor for Cure Following Treatment of Onychomycosis?

By No Comments
INTRODUCTIONOnychomycosis is a common problem in dermatology and podiatry practice that can result in significant morbidity.1,2 It can be a challenge to treat successfully, and while experience leads us to…
Read More
Dec 10
Love0

Increased Prevalence of Cancer in Adult Patients With Psoriasis in the United States: A Claims Based Analysis

By No Comments
INTRODUCTIONPsoriasis (Ps) is a chronic autoimmune disease manifesting itself as red, thick, and flaky skin patches that can occur anywhere on the body and that can become painful and itchy.1…
Read More
Dec 10
Love0

Prevalence of Psoriasis in Children and Adolescents in the United States: A Claims-Based Analysis

By No Comments
INTRODUCTIONPsoriasis (Ps) is a chronic autoimmune inflammatory disease that can affect the skin of almost any part of the body as well as the nails and scalp.1 It typically presents…
Read More
Dec 10
Love0

Impact of Gene Expression Profiling on Decision-Making in Clinically Node Negative Melanoma Patients after Surgical Staging

By No Comments
INTRODUCTION The incidence of cutaneous melanoma in the U.S. continues to increase, rising from 1 in 250 persons in 1980 to 1 in 53 in 2010.1 The American Cancer Society…
Read More
« Previous
NextPrevious »

Search page

Advertisement

Popular

  • Psoriatic Arthritis Awareness Month May 11, 2026
  • GLP-1 Therapies and Dermatology: A Brief Guide May 7, 2026
  • The Influence of Dermatologists’ Use of Social Media on Attracting Patients May 6, 2026
  • Podcast Refresher: Have You Listened To These Episodes? May 5, 2026
  • Racial and Ethnic Representation in Clinical Trials of Janus Kinase Inhibitors for Dermatologic Conditions: A Systematic Review May 4, 2026

Advertisement

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
CONTACT US     |      FEEDBACK    |      TERMS     |      COOKIE POLICY    |     PRIVACY    |      EDITORIAL POLICY    |     ADVERTISING POLICY  |    MANAGE PREFERENCES  |  YOUR PRIVACY CHOICES

News Topics

  • Inclusive Derm Atlas
  • Atopic Dermatitis
  • CME
  • Featured Articles
  • Issue Highlights
  • Oats in Skincare
  • Oncoderm
  • Pigmentary Disorders
  • Psoriasis
  • Skin of Color
DermAtlas        Derm In-Review         PDE        Next Steps in Derm         Skin of Color Update     ODAC Dermatology, Aesthetic & Surgical Conference

Journal of Drugs in Dermatology

  • About Us
  • Contact Us
  • Contact Sales
  • Editorial Board
  • eJDD
  • Institutional, Library, & Corporate Subscriptions
  • Log In
  • Open Access
  • Permissions Request
  • Podcast Sponsorship
  • Subscription Info
  • Store

© 2026 Journal of Drugs in Dermatology. All Rights Reserved. JDD, a peer-reviewed, MEDLINE®/PubMed® indexed journal, offers the dermatology community strong content of utmost quality and relevance on drugs, devices, and methods.

  • twitter
  • facebook
  • linkedin
  • instagram
Close Menu
  • Home
  • Issues
    • Current Issue
    • eJDD
    • Featured Articles
    • Archived Issues
    • Supplement Library
    • Case Reports
    • Unlocked Access
    • JDD Corner
    • Clinical Solutions
  • Topics
    • Atopic Dermatitis
    • Oats in Skincare
    • Oncoderm
    • Pigmentary Disorders
    • Psoriasis
    • Inclusive Dermatology Atlas
    • Social and Technology
    • Latest News
  • CME
    • CME Activities
  • Multimedia
    • JDD Corner
    • Video Abstracts
    • Podcast
    • Webinars
    • Translational Lecture Series
    • Video Pearls
  • Info
    • About JDD
    • Advertisers
      • Media Kit
      • Podcast Sponsorship
      • Reprints Contact Us
    • Authors
      • Instructions to Authors
      • Submit a Manuscript
      • Author and Peer Review Login
    • Editorial Board
    • Events
    • Contact Editorial
    • Why Publish in the JDD?
    • Institutional, Library, & Corporate Subscriptions
    • Reprints Contact Us
    • SanovaWorks
  • Inclusive Derm Atlas
    • Online Gallery
    • Digital Edition
  • Subscribe Now
  • Log In

Search

  • x-twitter
  • facebook
  • linkedin
  • instagram